期刊文献+

隐匿性乙型肝炎79例临床与病理分析 被引量:5

Clinical and pathological analysis of 79 patients with occult hepatitis B
下载PDF
导出
摘要 目的:探讨隐匿性乙型肝炎的临床与病理特征。方法:应用荧光定量PCR及免疫组织化学方法,对79例不同HBV抗体阳性而肝功能反复异常者的临床与肝组织病理进行分析。结果:79例患者中,血清HBV DNA阳性27例(34.2%),肝组织中HBV DNA阳性59例(74.7%),差异具有显著性意义(χ2=26.1,P<0.01);肝组织病理检查结果显示慢性肝炎77例,其中大多数为轻中度损害,肝硬化早期2例;免疫组化检测结果显示肝组织中HB-sAg阳性11例,HBcAg阳性32例。结论:①隐匿性乙型肝炎患者肝组织中HBV DNA阳性率明显高于血清;②隐匿性乙型肝炎患者大多数存在不同程度肝损害,需要及时治疗。 Objective: To explore the clinical and pathological characteristic of patients with occult hepatitis B. Methods: HBV DNA were detected by real time fluorescence quantitative PCR. Specimen of the liver biopsy were examined by immuno chemistry. Results: HBV DNA were positive in the serum of 27 and in the specimen of the liver of 59 among the 79 patients, respectively; HBsAg and HBcAg in the specimen of the liver of 11 and 32 among the 79 patients were positive, respectively; 77 patients with chronic hepatitis and 2 patients with early hepatocirrhosis among 79 patients were showed by pathological examination of the liver biopsy. Conclusion: The positive rate of HBV DNA in the specimen of the liver is higher than that of in the serum; There are different damage in the liver of the patients with occult hepatitis B. These patients needto be treated.
出处 《中西医结合肝病杂志》 CAS 2006年第1期13-15,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词 隐匿性乙型肝炎 肝组织病理 免疫组化 occult hepatitis B liver biopsy immunochemistry
  • 引文网络
  • 相关文献

参考文献5

二级参考文献21

  • 1斯崇文.加强对乙型肝炎病毒变异的研究[J].中华传染病杂志,1996,14(3):127-128. 被引量:21
  • 2张复春,吴婉芬,董惠卿,蔡晓莉,魏绍静,冼超.定量聚合酶链反应检测血清中HBV DNA及其临床应用[J].中华传染病杂志,1997,15(1):24-27. 被引量:130
  • 3骆抗先.乙型肝炎--基础与临床[M].北京:人民卫生出版社,1997.107-108.
  • 4Heijtink RA,Schneeberger PM,Postma B,et al.Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100IU/L seroprotection levels unreliable.Vaccine,2002,20: 2899-2905.
  • 5Weber B,Dengler T,Berger A,et al.Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.J Clin Microbiol,2003,41:135-143.
  • 6Weber B,Melchior W,Gehrke R,et al.Hepatitis B virus markers in Anti-HBc only positive individuals.J Med Virol,2001,64:312-319.
  • 7Iwai K, TashimaM, Itoh M, et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg- negative, HbsAb- positive recipient; reactivation of dormant virus during the immunosuppressive period[J].Bone Marrow Transplant, 2000,25:105 - 108.
  • 8McClary H, Koch R, Chisari FV, etal. Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice[J]. J Exp Med, 2000,192:289-294.
  • 9Fukai K, Yokosuka O, Fujiwara K, et al. Etiologic considerations of fulminant non - A, non - B viral hepatitis in Japan: analysis by nucleic acid amplification method[J]. Infect Dis, 1998, 178:325 - 333.
  • 10Kosly, Raien. Hepatitis B virus: Molecular mechanisms in disease and hovel strategies for therapy[M]. Imperial College Press: Distributed by world Scientific. c 1998.

共引文献1363

同被引文献39

引证文献5

二级引证文献17

;
使用帮助 返回顶部